145 related articles for article (PubMed ID: 34865321)
1. Risk factors for in-hospital mortality in patients with advanced lung cancer with interstitial pneumonia undergoing systemic chemotherapy: A retrospective and observational study using a nationwide administrative database in Japan.
Shiraishi T; Oda K; Yamasaki K; Kido T; Sennari K; Mukae H; Ohtani M; Fujino Y; Matsuda S; Fushimi K; Yatera K
Thorac Cancer; 2022 Jan; 13(2):236-246. PubMed ID: 34865321
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
[TBL] [Abstract][Full Text] [Related]
3. Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study.
Wang F; Mishina S; Takai S; Le TK; Ochi K; Funato K; Matsuoka S; Ohe Y
Clin Ther; 2017 Jun; 39(6):1146-1160. PubMed ID: 28527959
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of extracorporeal membrane oxygenation for acute respiratory failure with interstitial lung disease: a case control nationwide dataset study in Japan.
Usagawa Y; Komiya K; Yamasue M; Fushimi K; Hiramatsu K; Kadota JI
Respir Res; 2021 Jul; 22(1):211. PubMed ID: 34303372
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia.
Watanabe N; Niho S; Kirita K; Umemura S; Matsumoto S; Yoh K; Ohmatsu H; Goto K
Anticancer Res; 2015 Mar; 35(3):1697-701. PubMed ID: 25750330
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
[TBL] [Abstract][Full Text] [Related]
7. Second-line Chemotherapy for Patients with Small Cell Lung Cancer and Interstitial Lung Disease.
Fujimoto D; Shimizu R; Kato R; Sato Y; Kogo M; Ito J; Teraoka S; Otoshi T; Nagata K; Nakagawa A; Otsuka K; Katakami N; Tomii K
Anticancer Res; 2015 Nov; 35(11):6261-6. PubMed ID: 26504060
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Hanibuchi M; Kakiuchi S; Atagi S; Ogushi F; Shimizu E; Haku T; Toyoda Y; Azuma M; Kondo M; Kawano H; Otsuka K; Sakaguchi S; Nokihara H; Goto H; Nishioka Y
Lung Cancer; 2018 Nov; 125():93-99. PubMed ID: 30429044
[TBL] [Abstract][Full Text] [Related]
9. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
Tanaka M; Koike R; Sakai R; Saito K; Hirata S; Nagasawa H; Kameda H; Hara M; Kawaguchi Y; Tohma S; Takasaki Y; Dohi M; Nishioka Y; Yasuda S; Miyazaki Y; Kaneko Y; Nanki T; Watanabe K; Yamazaki H; Miyasaka N; Harigai M
Mod Rheumatol; 2015 Jul; 25(4):609-14. PubMed ID: 25496409
[TBL] [Abstract][Full Text] [Related]
11. Association of Early Systemic Corticosteroid Therapy with Mortality in Patients with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A Retrospective Cohort Study Using a Nationwide Claims Database.
Morita K; Matsui H; Michihata N; Fushimi K; Yasunaga H
Am J Clin Dermatol; 2019 Aug; 20(4):579-592. PubMed ID: 31041733
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer.
Ito N; Masuda T; Nakashima T; Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Anticancer Res; 2021 Mar; 41(3):1497-1506. PubMed ID: 33788742
[TBL] [Abstract][Full Text] [Related]
14. The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan.
Kido T; Muramatsu K; Asakawa T; Otsubo H; Ogoshi T; Oda K; Kubo T; Fujino Y; Matsuda S; Mayumi T; Mukae H; Yatera K
BMC Pulm Med; 2018 Feb; 18(1):28. PubMed ID: 29415701
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in surgically managed non-small-cell lung cancer patients with evidence of interstitial pneumonia identified on preoperative radiology or incidentally on postoperative histology.
Maniwa T; Kondo H; Mori K; Sato T; Teramukai S; Ebina M; Kishi K; Watanabe A; Sugiyama Y; Date H
Interact Cardiovasc Thorac Surg; 2015 May; 20(5):641-6. PubMed ID: 25712985
[TBL] [Abstract][Full Text] [Related]
16. New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia.
Isobe K; Kaburaki K; Kobayashi H; Sano G; Sakamoto S; Takai Y; Makino T; Tochigi N; Iyoda A; Homma S
Lung Cancer; 2018 Nov; 125():253-257. PubMed ID: 30429029
[TBL] [Abstract][Full Text] [Related]
17. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
Sato T; Teramukai S; Kondo H; Watanabe A; Ebina M; Kishi K; Fujii Y; Mitsudomi T; Yoshimura M; Maniwa T; Suzuki K; Kataoka K; Sugiyama Y; Kondo T; Date H;
J Thorac Cardiovasc Surg; 2014 May; 147(5):1604-1611.e3. PubMed ID: 24267779
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of non-small-cell lung cancer with interstitial pneumonia: variation in cancer location, histopathology, and frequency of postoperative acute exacerbations in interstitial pneumonia.
Ogawa K; Uruga H; Fujii T; Fujimori S; Kohno T; Kurosaki A; Kishi K; Abe S
BMC Pulm Med; 2020 Nov; 20(1):307. PubMed ID: 33218332
[TBL] [Abstract][Full Text] [Related]
19. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
